SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of the enhanced xCELLigence RTCA Software Pro Version 2.8, an integrated software package for ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc (NYSE: A) today announced the release of a new 21 CFR Part 11 compliance software for the Agilent xCELLigence Real-Time Cell Analysis ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (A) (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL ®, a recently approved CAR ...
The new xCELLigence RTCA ePacer provides a solution that uses electrical pacing to functionally mature cardiomyocytes. SAN DIEGO--(BUSINESS WIRE)-- On March 11, 2019, ACEA Biosciences - A Part of ...
SAN DIEGO--(BUSINESS WIRE)--On March 11, 2019, ACEA Biosciences – A Part of Agilent unveiled the new xCELLigence® RTCA ePacer TM during their workshop held at the Society of Toxicology (SOT) Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results